TYLAN 200 DIN 00103594
Health Canada record
| Active ingredient(s) | TYLOSIN 200 MG |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1968 |
| Current status date | 30-Jul-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TYLOSIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02295725 | NOROTYL LA (TYLOSIN INJECTABLE SUSPENSION) | NORBROOK LABORATORIES LTD. | Solution | TYLOSIN 150 MG | Cancelled Post Market |
| 00103586 | TYLAN 50 FOR INJ 50MG | ELANCO DIVISION ELI LILLY CANADA INC | Liquid | TYLOSIN 50 MG | Cancelled Post Market |
| 00079219 | TYLOCINE INJ 200MG/ML | CORVEL, DIVISION OF ELI LILLY CANADA INC. | Liquid | TYLOSIN 200 MG | Cancelled Post Market |
| 00079200 | TYLOCINE INJ 50MG/ML | CORVEL, DIVISION OF ELI LILLY CANADA INC. | Liquid | TYLOSIN 50 MG | Cancelled Post Market |
| 00079227 | TYLOCINE TAB 200MG | CORVEL, DIVISION OF ELI LILLY CANADA INC. | Tablet | TYLOSIN 200 MG | Cancelled Post Market |
| 01923803 | TYLOCINE TAB 200MG | ELI LILLY CANADA INC | Tablet | TYLOSIN 200 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36034 | 2025-09-22 | Supplement to a New Drug Submission (SNDS) | Addition of an alternate drug product manufacturing site |
| 20495 | 2018-02-19 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 20255 | 2018-01-08 | Supplement to a New Drug Submission (SNDS) | CHANGE TO PRESCRIPTION STATUS. LABELLING UPDATES |
International API supply for TYLOSIN
0 active FDA Drug Master Files.
Request a quote for TYLAN 200